Izervay is specifically designed to target the complement system, which plays a significant role in the progression of geographic atrophy. This makes it different from other AMD treatments like anti-VEGF therapy, which primarily target abnormal blood vessel growth.
How is Izervay different from other treatments for AMD?
Share This Story, Choose Your Platform!
About the Author: Staff Writer
World Eyecare Foundation staff writers are experienced eye care providers, researchers, academicians, industry leaders and practicing ophthalmologists and optometrist from around the world. Content may be generated by AI and is reviewed by the editorial team and specialists in the areas of publications.
Leave A Comment